We are live on ! Find out more
UTHR icon

United Therapeutics
UTHR

475 hedge funds and large institutions have $9.94B invested in United Therapeutics in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 192 increasing their positions, 161 reducing their positions, and 74 closing their positions.

New
Increased
Maintained
Reduced
Closed

30% more call options, than puts

Call options by funds: $22.4M | Put options by funds: $17.2M

19% more repeat investments, than reductions

Existing positions increased: 192 | Existing positions reduced: 161

2% less capital invested

Capital invested by funds: $10.1B → $9.94B (-$195M)

2.48% less ownership

Funds ownership: 98.65% → 96.18% (-2.5%)

6% less funds holding

Funds holding: 506 → 475 (-31)

18% less funds holding in top 10

Funds holding in top 10: 17 → 14 (-3)

39% less first-time investments, than exits

New positions opened: 45 | Existing positions closed: 74

Holders
475
Holders Change
-31
Holders Change %
-6.13%
% of All Funds
7.46%
Holding in Top 10
14
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-17.65%
% of All Funds
0.22%
New
45
Increased
192
Reduced
161
Closed
74
Calls
$22.4M
Puts
$17.2M
Net Calls
+$5.14M
Net Calls Change
+$7.57M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$201M
2
O
OrbiMed
New York
+$89M
3
BlackRock
BlackRock
New York
+$76.4M
4
ITP
Iron Triangle Partners
Connecticut
+$44.3M
5
AQR Capital Management
AQR Capital Management
Connecticut
+$30.4M

Top Sellers

1
Envestnet Asset Management
Envestnet Asset Management
Illinois
-$107M
2
FCM
Farallon Capital Management
California
-$104M
3
PCH
Polar Capital Holdings
United Kingdom
-$72.6M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$44.4M
5
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
-$39.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
251
Achmea Investment Management
Netherlands
$1.07M -$20.6K -93 -2%
GIBU
252
Gulf International Bank (UK)
United Kingdom
$1.05M -$295K -1,331 -22%
WMSA
253
Weiss Multi-Strategy Advisers
New York
$1.04M +$387K +1,745 +59%
Bessemer Group
254
Bessemer Group
New Jersey
$1.02M +$8.42K +38 +0.8%
II
255
Inspire Investing
Idaho
$1.02M +$103K +464 +11%
CGH
256
Crossmark Global Holdings
Texas
$1.01M -$58.5K -264 -6%
LAM
257
Lifestyle Asset Management
Texas
$981K +$985K +4,445 New
Fisher Asset Management
258
Fisher Asset Management
Washington
$960K +$5.09K +23 +0.5%
SAM
259
Securian Asset Management
Minnesota
$934K +$22.1K +100 +2%
QC
260
Quent Capital
New York
$932K -$665 -3 -0.1%
BCIM
261
British Columbia Investment Management
British Columbia, Canada
$921K +$25.5K +115 +3%
TPCW
262
TD Private Client Wealth
New York
$914K -$54.9K -248 -6%
Bank of Nova Scotia
263
Bank of Nova Scotia
Ontario, Canada
$907K -$49.8K -225 -5%
MCM
264
Mork Capital Management
California
$905K – – –
EP
265
Edgestream Partners
New Jersey
$896K +$900K +4,061 New
CB
266
Cadence Bank
Mississippi
$879K -$10.9K -49 -1%
SMDAM
267
Sumitomo Mitsui DS Asset Management
Japan
$849K +$33.7K +152 +4%
M&T Bank
268
M&T Bank
New York
$846K +$14.6K +66 +2%
EF
269
Empirical Finance
Pennsylvania
$828K +$430K +1,942 +107%
SP
270
Symmetry Partners
Connecticut
$800K – – –
FAM
271
Formidable Asset Management
Ohio
$791K +$78.4K +354 +11%
CIA
272
Capital Impact Advisors
Massachusetts
$774K +$777K +3,507 New
MSRPS
273
Maryland State Retirement & Pension System
Maryland
$774K – – –
HPM
274
Hudson Portfolio Management
New York
$768K – – –
TD Asset Management
275
TD Asset Management
Ontario, Canada
$742K +$10.9K +49 +1%
9 10
11
12 13

UTHR Hedge Fund Activity: Q2 2023 in Review

475 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in United Therapeutics (UTHR) for Q2 2023, worth a combined $9.94B — down 1.9% from $10.1B a quarter earlier.

Sellers outnumbered buyers: 74 funds closed out of UTHR and 45 opened new positions — a net loss of 29 holders — while 161 trimmed existing stakes and 192 added.

The largest buyer was Wellington Management Group, adding an estimated $201M. The largest seller was Envestnet Asset Management, cutting an estimated $107M.

  • 475 institutional investors held United Therapeutics (UTHR) as of Q2 2023, down from 506 in Q1 2023.
  • Funds reported $9.94B of United Therapeutics stock for Q2 2023, down 1.9% quarter-over-quarter.
  • 45 funds opened new United Therapeutics positions in Q2 2023 and 74 closed out, a net change of -29 holders.
  • The largest United Therapeutics buyer in Q2 2023 was Wellington Management Group, an estimated $201M added.
  • The largest United Therapeutics seller in Q2 2023 was Envestnet Asset Management, an estimated $107M sold.

Based on aggregated 13F filings for Q2 2023.